Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Busch

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cellsSarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcomeGöran Jönsson, Christian Busch, Stian Knappskog, et al.
Circulation|June 11, 2003
Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosusCarsten Schneider, Edda Bahlmann, Matthias Antz, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 StatusChristian Leischner, Markus Burkard, Anja Michel, et al.
Molecular Cancer|February 19, 2018
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotypeTobias Sinnberg, Mitchell P Levesque, Jelena Krochmann, et al.
Cells|January 21, 2023
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant MelanomaMarkus Burkard, Heike Niessner, Christian Leischner, et al.
Plos One|September 12, 2013
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanomaAndliena Tahiri, Kathrine Røe, Anne H Ree, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Frontiers in Immunology|March 13, 2023
Phenotypic diversity of human adipose tissue-resident NK cells in obesityMartha E Haugstøyl, Martin Cornillet, Kristina Strand, et al.
Cells|April 12, 2022
Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In VivoHeike Niessner, Markus Burkard, Christian Leischner, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cellsSarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcomeGöran Jönsson, Christian Busch, Stian Knappskog, et al.
Circulation|June 11, 2003
Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosusCarsten Schneider, Edda Bahlmann, Matthias Antz, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 StatusChristian Leischner, Markus Burkard, Anja Michel, et al.
Molecular Cancer|February 19, 2018
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotypeTobias Sinnberg, Mitchell P Levesque, Jelena Krochmann, et al.
Cells|January 21, 2023
High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant MelanomaMarkus Burkard, Heike Niessner, Christian Leischner, et al.
Plos One|September 12, 2013
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanomaAndliena Tahiri, Kathrine Røe, Anne H Ree, et al.
Frontiers in Oncology|September 10, 2014
Epigenetic impacts of ascorbate on human metastatic melanoma cellsSascha Venturelli, Tobias W Sinnberg, Alexander Berger, et al.
Frontiers in Immunology|March 13, 2023
Phenotypic diversity of human adipose tissue-resident NK cells in obesityMartha E Haugstøyl, Martin Cornillet, Kristina Strand, et al.
Cells|April 12, 2022
Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In VivoHeike Niessner, Markus Burkard, Christian Leischner, et al.
Pageof 8